Center-Authored Papers

Filters: Author is Plymate, Stephen R  [Clear All Filters]
2008
Sprenger CCT, Drivdahl RH, Woodke LB, Eyman D, Reed MJ, Carter WG, Plymate SR.  2008.  Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.. Neoplasia (New York, N.Y.). 10(12):1350-61. Abstract
2009
Sprenger CCT, Haugk K, Sun S, Coleman I, Nelson PS, Vessella RL, Ludwig DL, Wu JD, Plymate SR.  2009.  Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(24):7634-7641. Abstract
2010
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA, Watson SG et al..  2010.  Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.. Journal of Alzheimer's disease : JAD. 22(2):569-79. Abstract
Bianchi-Frias D, Vakar-Lopez F, Coleman IM, Plymate SR, Reed MJ, Nelson PS.  2010.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.. PloS one. 5(9) Abstract
Sun S, Sprenger CCT, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H et al..  2010.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.. The Journal of clinical investigation. 120(8):2715-30. Abstract
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson SG, Cholerton BA et al..  2010.  Effects of aerobic exercise on mild cognitive impairment: a controlled trial.. Archives of neurology. 67(1):71-9. Abstract
Schayek H, Seti H, Greenberg NM, Sun S, Werner H, Plymate SR.  2010.  Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.. Molecular and cellular endocrinology. 323(2):239-45. Abstract
2011
Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR.  2011.  Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.. PloS one. 6(11):e27970. Abstract
Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson SG, Bonner LM, Callaghan M, Leverenz JB, Walter BK et al..  2011.  Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.. Archives of neurology. 68(6):743-52. Abstract
Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery BR.  2011.  Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25. Abstract
2012
Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, Edwards J, Isaacs WB, Nelson PS, Bluemn E et al..  2012.  Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.. Cancer research. 72(14):3457-62. Abstract
Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, Hsieh C-C, Adisetiyo H, Roy-Burman P, Coleman I et al..  2012.  VEGF/Neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-1R define a novel mechanism of aggressive prostate cancer.. Cancer discovery. Abstract
2013
Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.  2013.  T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.. Breast cancer research and treatment. 139(3):657-65. Abstract
Dean JP, Sprenger CC, Wan J, Haugk K, Ellis WJ, Lin DW, Corman JM, Dalkin BL, Mostaghel E, Nelson PS et al..  2013.  Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation.. The Journal of clinical endocrinology and metabolism. 98(5):E820-8. Abstract
Liu G, Lu S, Wang X, Page ST, Higano CS, Plymate SR, Greenberg NM, Sun S, Li Z, Wu JD.  2013.  Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.. The Journal of clinical investigation. 123(10):4410-22. Abstract
2014
Mostaghel EA, Plymate SR, Montgomery B.  2014.  Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(4):791-8. Abstract
2015
Yu EY, Li H, Higano CS, Agarwal N, Pal SK, Alva A, Heath EI, Lam ET, Gupta S, Lilly MB et al..  2015.  SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(14):1601-8. Abstract
Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, Montgomery B, Taplin M-E, Pritchard CC, Attard G et al..  2015.  Integrative clinical genomics of advanced prostate cancer.. Cell. 161(5):1215-28. Abstract
Hickey TE, Irvine CM, Dvinge H, Tarulli GA, Hanson AR, Ryan NK, Pickering MA, Birrell SN, Hu DG, Mackenzie PI et al..  2015.  Expression of androgen receptor splice variants in clinical breast cancers.. Oncotarget. Abstract
2016
Henzler C, Li Y, Yang R, McBride T, Ho Y, Sprenger C, Liu G, Coleman I, Lakely B, Li R et al..  2016.  Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.. Nature communications. 7:13668. Abstract
2017
Zhu Y, Sharp A, Anderson CM, Silberstein JL, Taylor M, Lu C, Zhao P, De Marzo AM, Antonarakis ES, Wang M et al..  2017.  Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer.. European urology. Abstract
2019
Liu Y, Horn JL, Banda K, Goodman AZ, Lim Y, Jana S, Arora S, Germanos AA, Wen L, Hardin WR et al..  2019.  The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.. Science translational medicine. 11(503) Abstract